206 related articles for article (PubMed ID: 22102200)
1. Von Willebrand disease in children: diagnosis and management of a pediatric cohort in one single center in Argentina.
Bonduel M; Frontroth JP; Hepner M; Sciuccati G; Feliu-Torres A; Pieroni G
Semin Thromb Hemost; 2011 Jul; 37(5):560-7. PubMed ID: 22102200
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis and management of von Willebrand disease in South Africa.
Meiring M; Coetzee M; Kelderman M; Badenhorst P
Semin Thromb Hemost; 2011 Jul; 37(5):576-80. PubMed ID: 22102202
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of von Willebrand disease in a single institution of Argentina.
Woods AI; Sánchez-Luceros A; Meschengieser SS; Kempfer AC; Blanco AN; Lazzari MA
Semin Thromb Hemost; 2011 Jul; 37(5):568-75. PubMed ID: 22102201
[TBL] [Abstract][Full Text] [Related]
4. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
5. Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
Federici AB; Bucciarelli P; Castaman G; Baronciani L; Canciani MT; Mazzucconi MG; Morfini M; Rocino A; Schiavoni M; Oliovecchio E; Iorio A; Mannucci PM
Semin Thromb Hemost; 2011 Jul; 37(5):511-21. PubMed ID: 22102194
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
[TBL] [Abstract][Full Text] [Related]
7. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of von Willebrand disease in Australia.
Favaloro EJ; Bonar R; Favaloro J; Koutts J
Semin Thromb Hemost; 2011 Jul; 37(5):542-54. PubMed ID: 22102198
[TBL] [Abstract][Full Text] [Related]
9. Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Chuit R; Turdó K; Blanco A; Lazzari MA
Thromb Haemost; 2010 Nov; 104(5):984-9. PubMed ID: 20886181
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of von Willebrand disease in The Netherlands.
de Wee EM; Leebeek FW; Eikenboom JC
Semin Thromb Hemost; 2011 Jul; 37(5):480-7. PubMed ID: 22102190
[TBL] [Abstract][Full Text] [Related]
11. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of von Willebrand disease in Spain.
Batlle J; Perez-Rodriguez A; Pinto JC; Fraga EL; Rodriguez-Trillo Tch A; Fernanda Lopez-Fernandez M
Semin Thromb Hemost; 2011 Jul; 37(5):503-10. PubMed ID: 22102193
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, diagnosis, and management of von Willebrand disease in India.
Ghosh K; Shetty S
Semin Thromb Hemost; 2011 Jul; 37(5):595-601. PubMed ID: 22102205
[TBL] [Abstract][Full Text] [Related]
14. Laboratory diagnosis and management of von Willebrand disease in Turkey: Izmir experience.
Akin M; Kavakli K
Semin Thromb Hemost; 2011 Jul; 37(5):581-6. PubMed ID: 22102203
[TBL] [Abstract][Full Text] [Related]
15. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ; van de Velde A; van Vliet HH; van der Planken M; Schroyens W; Berneman Z
Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
[TBL] [Abstract][Full Text] [Related]
16. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Asatiani E; Kessler CM;
Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
[TBL] [Abstract][Full Text] [Related]
17. Highly purified VWF/FVIII concentrates in the treatment and prophylaxis of von Willebrand disease: the PRO. WILL Study.
Federici AB
Haemophilia; 2007 Dec; 13 Suppl 5():15-24. PubMed ID: 18078393
[TBL] [Abstract][Full Text] [Related]
18. Bleeding tendency and efficacy of anti-haemorrhagic treatments in patients with type 1 von Willebrand disease and increased von Willebrand factor clearance.
Castaman G; Tosetto A; Federici AB; Rodeghiero F
Thromb Haemost; 2011 Apr; 105(4):647-54. PubMed ID: 21264446
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder.
Favaloro EJ
Semin Thromb Hemost; 2011 Jul; 37(5):440-55. PubMed ID: 22102186
[TBL] [Abstract][Full Text] [Related]
20. Characterization, classification, and treatment of von Willebrand diseases: a critical appraisal of the literature and personal experiences.
Michiels JJ; Gadisseur A; Budde U; Berneman Z; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Semin Thromb Hemost; 2005 Nov; 31(5):577-601. PubMed ID: 16276467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]